From Cell Biology to Tissue Engineering


In-situ analysis of mast cells and dendritic cells in coronary atherosclerosis in chronic kidney disease (CKD)

D.L. Wachter1*, D. Neureiter5*, V. Câmpean4, K.F. Hilgers3, M. Büttner-Herold4, C. Daniel4, K. Benz2+ and K. Amann1+

1Department of Pathology, 2Department of Pediatrics, 3Department of Nephrology, 4Department of Nephropathology, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Germany and 5Department of Pathology, University of Salzburg, Salzburg, Austria
*: shared first author
+: shared senior author

Offprint requests to: Prof. Dr. Kerstin Amann, Department of Nephropathology, University of Erlangen-Nürnberg, Krankenhausstr. 8-10, 91054 Erlangen, Germany. e-mail: kerstin.amann@uk-erlangen.de

Summary. Aims. Mast cells (MC) and dendritic cells (DC) have immune modulatory function and can influence T-cell activity. Both cell types have been found in atherosclerotic plaques and are thought to play an important role for plaque stability. Compared to matched segments of the non-renal population, patients with chronic kidney disease (CKD) show a more pronounced and more aggressive course of atherosclerosis with higher plaque calcification and significantly higher complication rates. It was the aim of this study to analyze the number and localization of MCs and DCs, macrophages, T- and B-cells as well as the expression of markers of inflammation such as CRP and NFκB in calcified and non-calcified atherosclerotic plaques of patients with CKD and control patients. Methods. Fifty coronary atherosclerotic plaques from patients with endstage CKD (CKD, n=25) and control (n=25) patients were categorized according to the Stary classification and investigated using immunohistochemistry (markers for MC, DC, T, B, macrophage and NFκB). Expression was analyzed separately for the complete plaque area as well as for the different plaque subregions and correlations were analyzed. Results. We found only very few DCs and MCs per lesion area with slightly increased numbers in calcified plaques. MCs per plaque area were significantly more frequent in CKD than in control patients and this was independent of plaque calcification. MCs were most frequently found in the shoulder and basis of the plaque. DCs per plaque area were significantly less in calcified plaques of CKD compared to control patients. In control, but not in CKD patients, DCs were significantly more frequent in calcified than in non-calcified plaques. Within the plaques, DCs were similarly distributed between all 4 subregions. Conclusions. Coronary atherosclerotic plaques of CKD patients showed a significantly higher number of MCs whereas DCs were less frequent compared to control patients particularly if plaques were calcified. These findings might indicate a potential proinflammatory role of MCs, but not of DCs in atherosclerotic lesions of CKD patients, adding another characteristic of advanced atherosclerosis in these patients. Histol Histopathol 33, 871-886 (2018)

Key words: Atherosclerosis, Chronic kidney disease, Mast cells, Dendritic cells, Cardiovascular disease

DOI: 10.14670/HH-11-988